The $260 million deal set the basis for a broader potential multi-billion dollar payout to some 2,700 addiction-ravaged communities who had signed on to the Cleveland lawsuit, the first in a federal court to address the causes of the crisis.
It is the first settlement to come out of the recent coast-to-coast wave of nearly 2,000 lawsuits against Purdue Pharma over allegations that they helped create the nation's deadly opioid crisis with aggressive marketing of the powerful painkiller.